Operating Agreements in the Biotechnology Industry
8 Contracts & Agreements
- Amendment, dated April 28, 2022, to Joint Operating Agreement, dated August 6, 2021, by and among European Wellness Biomedical Group, Bio Peptides LLC and the Registrant (VITRO DIAGNOSTICS INC, Filed With SEC on September 9, 2022)
- Joint Operating Agreement, dated August 6, 2021, by and among European Wellness Biomedical Group, Bio Peptides LLC and the Registrant (VITRO DIAGNOSTICS INC, Filed With SEC on September 9, 2022)
- Joint Operating Agreement, dated July 14, 2020, by and between The Partners Stem Cell Centre (PSCC) Ltd. and the Registrant (VITRO DIAGNOSTICS INC, Filed With SEC on September 9, 2022)
- Operating Agreement of RE Ventures I, LLC, by and between Rallybio IPB, LLC and Exscientia Limited, dated July 19, 2019 (Rallybio Corp, Filed With SEC on July 2, 2021)
- AMENDED AND RESTATED OPERATING AGREEMENT OF PCT, LLC, A CALADRIUS COMPANY (A DELAWARE LIMITED LIBAILITY COMPANY) DATED AS OF MARCH 11, 2016 (CALADRIUS BIOSCIENCES, INC., Filed With SEC on May 5, 2016)
- AMENDMENT TO INTERIM CHIEF OPERATINGOFFICER AGREEMENT (AmpliPhi Biosciences Corp, Filed With SEC on April 16, 2015)
- AMPLIPHIBIOSCIENCES CORPORATION INTERIMCHIEF OPERATING OFFICER AGREEMENT (AmpliPhi Biosciences Corp, Filed With SEC on November 14, 2014)
- LETTER OF AGREEMENT by and between The INTERNATIONAL UNION of OPERATING ENGINEERS LOCAL 302 and NW BIOTHERAPEUTICS (Tenant) (NORTHWEST BIOTHERAPEUTICS INC, Filed With SEC on June 4, 2007)
